3 Stocks That Are Set for Monster Growth in 2022


American City Business Journals

Viatris keen to increase dividends

Canonsburg-based drug manufacturer Viatris Inc. said its initial return to shareholders in 2022 will come in the form of dividends, with CEO Michael Goettler not completely shutting the door on stock buybacks but saying the latter was a more complex issue. Viatris (NYSE: VTRS), which will turn a year old next week, is the combination of Mylan NV and the Upjohn unit of Pfizer Inc. (NYSE: PFE). Viatris had earnings of $311.5 million, 26 cents a share, on revenue of $4.5 billion, compared to $185.7 million, 36 cents a share, on revenue of $2.9 million for Mylan and Upjohn a year ago.

‘I use credit cards for everything’: I’m 36, earn $62,000 and have $290,000 in retirement savings. My wife is a stay-at-home mom. Are we doing OK?

Previous article

Palantir reports 36% revenue growth, projects strong finish to year

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News